These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3293155)

  • 21. Cytokine therapy for metastatic renal cell carcinoma.
    Bukowski RM
    Semin Urol Oncol; 2001 May; 19(2):148-54. PubMed ID: 11354535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary metastasized hypernephroma: therapy and follow-up].
    Hienert VG; Latal D; Kühböck J; Rummelhardt S
    Z Urol Nephrol; 1987 Dec; 80(12):669-74. PubMed ID: 3442132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents].
    Kakehi Y; Yoshida O; Segawa T; Kanematsu A; Hiura M; Shichiri Y; Arai Y
    Hinyokika Kiyo; 1994 Oct; 40(10):925-9. PubMed ID: 7992710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ifosfamide chemotherapy of metastatic renal cell cancer.
    Bodrogi I; Baki M; Sinkovics I; Eckhardt S
    Semin Surg Oncol; 1988; 4(2):95-6. PubMed ID: 3393779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Second-line thalidomide/IL-2 therapy in metastatic kidney cancer--results of a pilot study].
    Schrader AJ; Heidenreich A; Hegele A; Olbert P; Varga Z; Hofmann R
    Aktuelle Urol; 2006 Nov; 37(6):429-35; quiz 423-4. PubMed ID: 17099831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapeutics for metastatic renal cell carcinoma.
    Hutson TE; Figlin RA
    Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New targets and drugs for treatment of advanced renal cell carcinoma].
    Rohde D
    Aktuelle Urol; 2005 Apr; 36(2):125-30. PubMed ID: 15902572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic renal cancer and patient survival as a criterion of treatment response.
    Stathopoulos GP; Koutantos J; Rigatos SK; Stathopoulos J; Batzios S; Batziou C
    Oncol Rep; 2008 Feb; 19(2):477-81. PubMed ID: 18202797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drug therapies for advanced renal cell carcinoma.
    Gore ME; Harrison ML; Montes A
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):57-71. PubMed ID: 17187520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
    Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
    Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapy of renal cell cancer.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytokine therapy for metastatic renal cell carcinoma].
    Eto M; Naito S
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1738-44. PubMed ID: 12402423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine.
    Sommer HH; Fosså SD; Lien HH
    Cancer Chemother Pharmacol; 1985; 14(3):277-8. PubMed ID: 3995687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 35. The end of chemotherapy in renal cell carcinoma: for much but not for all.
    Iacovelli R; Raimondi C; Palazzo A
    Am J Clin Oncol; 2010 Oct; 33(5):522-3. PubMed ID: 20924226
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of metastatic kidney cancer in elderly subjects].
    Escudier B; Paparel P; Neuzillet Y; Long JA; Rioux-Leclercq N; Correas JM; Lang H; Poissonnier L; Baumert H; Mejean A; Patard JJ
    Prog Urol; 2009 Nov; 19 Suppl 3():S129-32. PubMed ID: 20123496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapeutic strategies for renal cell carcinoma.
    Milowsky MI; Nanus DM
    Urol Clin North Am; 2003 Aug; 30(3):601-9, x. PubMed ID: 12953758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cancer chemotherapy today and in the future].
    Tanneberger S
    Z Gesamte Inn Med; 1990 Dec; 45(23):693-5. PubMed ID: 2102024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
    Isaacs WB; Isaacs JT; Kyprianou N; Burgers JK; Alexander RB; Partin AW; Mohler JL; Marshall FF; Coffey DS
    Eur Urol; 1990; 18 Suppl 2():33-5. PubMed ID: 2226604
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.
    Guimaraes JL; Ghosn M; Ostronoff M; Azab M; Theodore C; Droz JP
    Cancer Invest; 1990; 8(6):623-4. PubMed ID: 2292054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.